Spatial aspects of oncogenic signalling determine the response to combination therapy in slice explants from Kras -driven lung tumours-Reference-Cited by-同舟云学术

Spatial aspects of oncogenic signalling determine the response to combination therapy in slice explants from Kras -driven lung tumours

Published:2018-04-02 Issue:1 Volume:245 Page:101-113
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:J. Pathol

Author:

Närhi Katja¹,Nagaraj Ashwini S¹^ORCID,Parri Elina¹,Turkki Riku¹,van Duijn Petra W²,Hemmes Annabrita¹,Lahtela Jenni¹,Uotinen Virva¹,Mäyränpää Mikko I³⁴,Salmenkivi Kaisa⁴,Räsänen Jari⁵,Linder Nina¹,Trapman Jan⁶,Rannikko Antti⁷,Kallioniemi Olli¹,Af Hällström Taija M¹⁸,Lundin Johan¹,Sommergruber Wolfgang⁹,Anders Simon¹¹⁰^ORCID,Verschuren Emmy W¹^ORCID

Affiliation:

1. Institute for Molecular Medicine Finland (FIMM), HiLIFE; University of Helsinki; Helsinki Finland

2. Department of Urology, Josephine Nefkens Institute; Erasmus Medical Center; Rotterdam The Netherlands

3. Department of Pathology; University of Helsinki; Helsinki Finland

4. HUSLAB, Division of Pathology; Helsinki University Hospital; Helsinki Finland

5. Heart and Lung Centre, Department of General Thoracic and Oesophageal Surgery; Helsinki University Hospital; Helsinki Finland

6. Department of Pathology, Josephine Nefkens Institute; Erasmus Medical Centre; Rotterdam The Netherlands

7. Department of Urology; Helsinki University Hospital; Helsinki Finland

8. Orion Corporation; Orion Pharma Espoo Finland

9. Department of Lead Discovery; Boehringer Ingelheim RCV GmbH & Co. KG; Vienna Austria

10. Centre for Molecular Biology of the University of Heidelberg (ZMBH); Heidelberg Germany

Funder

Innovative Medicines Initiative Joint Undertaking grant agreement

European Union's Seventh Framework Programme

EFPIA

Tekes

Deutsche Forschungsgemeinschaft

University of Helsinki Doctoral Programme in Biomedicine scholarships

Sigrid Juselius and Orion-Farmos Foundations (EWV)

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/path.5059/fullpdf

Reference44 articles.

1. New and emerging targeted treatments in advanced non-small-cell lung cancer;Hirsch;Lancet,2016

2. Biological and therapeutic impact of intratumor heterogeneity in cancer evolution;McGranahan;Cancer Cell,2015

3. Leveraging signaling research to understand and treat disease;Yaffe;Sci Signal,2016

4. Capturing complex tumour biology in vitro: histological and molecular characterisation of precision cut slices;Davies;Sci Rep,2015

5. Synergistic effects of crizotinib and temozolomide in experimental FIG-ROS1 fusion-positive glioblastoma;Das;Cancer Growth Metastasis,2015

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of Dual Diagnostic-Therapeutic Nanoformulation Effective Against Pancreatic Cancer in Animal Model;International Journal of Nanomedicine;2024-09

2. Precision cut lung slices: an integrated ex vivo model for studying lung physiology, pharmacology, disease pathogenesis and drug discovery;Respiratory Research;2024-06-01

3. Hydrogel-embedded precision-cut lung slices supportex vivoculture ofin vivo-induced premalignant lung lesions;2024-05-02

4. A Novel Method for Floxed Gene Manipulation Using TAT-Cre Recombinase in Ex Vivo Precision-Cut Lung Slices (PCLS);BIO-PROTOCOL;2024

5. Hydrogel‐Embedded Precision‐Cut Lung Slices Model Lung Cancer Premalignancy Ex Vivo;Advanced Healthcare Materials;2023-11-27